Mearex (NASDAQ: MEDX) is an American biotechnology company based in Princeton, New Jersey. The company has manufacturing facilities in Bloomsbury and Annandale, New Jersey, and research facilities in Milpitas and Sunnyvale, California. Medarex specializes in therapeutic products based on monoclonal antibodies.